0001104659-21-150000.txt : 20211215 0001104659-21-150000.hdr.sgml : 20211215 20211215161849 ACCESSION NUMBER: 0001104659-21-150000 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211213 FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirschbaum Mark CENTRAL INDEX KEY: 0001830211 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 211494413 MAIL ADDRESS: STREET 1: 66 WEST 38TH STREET, APT. 19D CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2135363d1_4.xml OWNERSHIP DOCUMENT X0306 4 2021-12-13 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001830211 Kirschbaum Mark C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 3.45 2021-12-13 4 A 0 100000 0 A 2031-12-13 Common Stock 100000 100000 D These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis. These securities were granted as part of the Issuer's annual compensation review to executive officers. /s/ Mark Kirschbaum 2021-12-15